| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ZFP36 ring finger protein | 0.523 | 0.692 | 0.75 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 0.743 | 0.269 | 0.78 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | 0.621 | 0.500 | 0.96 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
WD repeat domain 1 | 0.623 | 0.654 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
vitronectin | 0.509 | 0.769 | 1.5E-10 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
vascular endothelial growth factor B | 0.592 | 0.615 | 1.3E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.330 | None | 1.000 | 4 | 0 | 2004 | 2009 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
urocortin 3 | 0.593 | 0.731 | 4.4E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
urocortin | 0.539 | 0.769 | 0.45 |
|
phenotype | 0.310 | None | 1.000 | 2 | 0 | 1999 | 2003 | ||||||||
|
transmembrane immune signaling adaptor TYROBP | 0.573 | 0.769 | 0.20 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
thioredoxin interacting protein | 0.490 | 0.731 | 0.16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
thymic stromal lymphopoietin | 0.486 | 0.808 | 4.0E-03 |
|
phenotype | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.520 | None | 1.000 | 5 | 0 | 2007 | 2011 | ||||||||
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
three prime repair exonuclease 1 | 0.517 | 0.808 | 0.58 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
triggering receptor expressed on myeloid cells like 2 | 0.861 | 0.192 | 1.1E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
triggering receptor expressed on myeloid cells 1 | 0.515 | 0.808 | 6.3E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
tryptase alpha/beta 1 | 0.722 | 0.500 | 1.3E-13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2005 | ||||||||
|
tumor protein p73 | 0.449 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2008 |